Coherus Biosciences Inc. appointed Dr. V. Bryan Lawlis, Jr. as Chairman to its Scientific Advisory Board. Dr. Lawlis, a biotech industry veteran, has extensive experience in manufacturing biotechnology and other pharmaceutical products, research and development of drug products, conducting clinical trials and the regulatory processes. Dr. Lawlis is a founder and currently serves as the President and Chief Executive Officer of Itero Biopharmaceuticals Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | +9.09% |
|
+24.14% | -45.95% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.95% | 19Cr | |
+20.17% | 13TCr | |
+24.67% | 12TCr | |
+25.44% | 2.77TCr | |
-17.74% | 2.03TCr | |
-15.17% | 1.68TCr | |
-15.21% | 1.56TCr | |
+11.91% | 1.48TCr | |
-47.10% | 1.46TCr | |
+54.50% | 1.44TCr |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Coherus Biosciences Inc. Announces Appointment of V. Bryan Lawlis, Jr. as Chairman of its Scientific Advisory Board